Perbedaan Organon Pharma Indonesia Tbk. dan Buana Artha Anugerah Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Buana Artha Anugerah Tbk. diperdagangkan di Rp376 (kapitalisasi pasar 1,75 T, volume 24 jam 79,9 rb). Perbedaan utamanya: Buana Artha Anugerah Tbk. jauh lebih besar — sekitar 16,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | STAR | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 1,75 T |
Volume | — | 79,9 rb |
Lot | — | 799 |
Perputaran | — | 29,25 jt |
Harga Rata-rata | — | 366,08 |
Nilai Transaksi | — | 29,25 jt |
Harga Ekuilibrium Indikatif | — | 376 |
Volume Ekuilibrium Indikatif | — | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Star Petrochem Tbk (the company) was established under its original name of PT Star Asia International base on notarial deed No.34 of Pahala Sutrisno, S.H, dated on 19 May, 2008. The Company’s articles of association has been amended several times, most recently by notarial deed No. 98 of Yulia, S.H., dated Feb 11, 2011, concerning among others, the change in the Company’s name, and public offering.
Selengkapnya di halaman STAR →